최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기생명과학회지 = Journal of life science, v.31 no.5, 2021년, pp.527 - 535
Lysosomes are organelles surrounded by membranes that contain acid hydrolases; they degrade proteins, macromolecules, and lipids. According to nutrient conditions, lysosomes act as signaling hubs that regulate intracellular signaling pathways and are involved in the homeostasis of cells. Therefore, ...
Assaraf, Y. G. 2006. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis. Drug Resist. Updat. 9, 227-246.
Ballabio, A. and Bonifacino, J. S. 2020. Lysosomes as dynamic regulators of cell and organismal homeostasis. Nat. Rev. Mol. Cell Biol. 21, 101-118.
Boya, P., Gonzalez-Polo, R. A., Poncet, D., Andreau, K., Vieira, H. L., Roumier, T., Perfettini, J. L. and Kroemer, G. 2003. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene 22, 3927-3936.
Boya, P. and Kroemer, G. 2008. Lysosomal membrane permeabilization in cell death. Oncogene 27, 6434-6451.
Bruchard, M., Mignot, G., Derangere, V., Chalmin, F., Chevriaux, A., Vegran, F., Boireau, W., Simon, B., Ryffel, B., Connat, J. L., Kanellopoulos, J., Martin, F., Rebe, C., Apetoh, L. and Ghiringhelli, F. 2013. Chemotherapy-triggered cathepsin b release in myeloid-derived suppressor cells activates the nlrp3 inflammasome and promotes tumor growth. Nat. Med. 19, 57-64.
Burgener, S. S., Leborgne, N. G. F., Snipas, S. J., Salvesen, G. S., Bird, P. I. and Benarafa, C. 2019. Cathepsin g inhibition by serpinb1 and serpinb6 prevents programmed necrosis in neutrophils and monocytes and reduces gsdmd-driven inflammation. Cell Rep. 27, 3646-3656.
Burger, A. M., Jenkins, T. C., Double, J. A. and Bibby, M. C. 1999. Cellular uptake, cytotoxicity and DNA-binding studies of the novel imidazoacridinone antineoplastic agent c1311. Br. J. Cancer 81, 367-375.
Cesen, M. H., Pegan, K., Spes, A. and Turk, B. 2012. Lysosomal pathways to cell death and their therapeutic applications. Exp. Cell Res. 318, 1245-1251.
Chapuy, B., Koch, R., Radunski, U., Corsham, S., Cheong, N., Inagaki, N., Ban, N., Wenzel, D., Reinhardt, D., Zapf, A., Schweyer, S., Kosari, F., Klapper, W., Truemper, L. and Wulf, G. G. 2008. Intracellular abc transporter a3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration. Leukemia 22, 1576-1586.
Chen, J. C., Uang, B. J., Lyu, P. C., Chang, J. Y., Liu, K. J., Kuo, C. C., Hsieh, H. P., Wang, H. C., Cheng, C. S., Chang, Y. H., Chang, M. D., Chang, W. S. and Lin, C. C. 2010. Design and synthesis of alpha-ketoamides as cathepsin s inhibitors with potential applications against tumor invasion and angiogenesis. J. Med. Chem. 53, 4545-4549.
de Duve, C., de Barsy, T., Poole, B., Trouet, A., Tulkens, P. and Van Hoof, F. 1974. Commentary. Lysosomotropic agents. Biochem. Pharmacol. 23, 2495-2531.
De Mei, C., Ercolani, L., Parodi, C., Veronesi, M., Lo Vecchio, C., Bottegoni, G., Torrente, E., Scarpelli, R., Marotta, R., Ruffili, R., Mattioli, M., Reggiani, A., Wade, M. and Grimaldi, B. 2015. Dual inhibition of rev-erbbeta and autophagy as a novel pharmacological approach to induce cytotoxicity in cancer cells. Oncogene 34, 2597-2608.
Duvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., Vander Heiden, M. G., MacKeigan, J. P., Finan, P. M., Clish, C. B., Murphy, L. O. and Manning, B. D. 2010. Activation of a metabolic gene regulatory network downstream of mtor complex 1. Mol. Cell 39, 171-183.
Fairn, G. D. and Grinstein, S. 2012. How nascent phagosomes mature to become phagolysosomes. Trends Immunol. 33, 397-405.
Feng, Y., He, D., Yao, Z. and Klionsky, D. J. 2014. The machinery of macroautophagy. Cell Res. 24, 24-41.
Ferrao, P., Sincock, P., Cole, S. and Ashman, L. 2001. Intracellular p-gp contributes to functional drug efflux and resistance in acute myeloid leukaemia. Leuk. Res. 25, 395-405.
Firestone, R. A., Pisano, J. M. and Bonney, R. J. 1979. Lysosomotropic agents. 1. Synthesis and cytotoxic action of lysosomotropic detergents. J. Med. Chem. 22, 1130-1133.
Gao, C., Ding, Y., Zhong, L., Jiang, L., Geng, C., Yao, X. and Cao, J. 2014. Tacrine induces apoptosis through lysosomeand mitochondria-dependent pathway in hepg2 cells. Toxicol. In Vitro 28, 667-674.
Gillet, J. P. and Gottesman, M. M. 2011. Advances in the molecular detection of abc transporters involved in multidrug resistance in cancer. Curr. Pharm. Biotechnol. 12, 686-692.
Goldman, S. D., Funk, R. S., Rajewski, R. A. and Krise, J. P. 2009. Mechanisms of amine accumulation in, and egress from, lysosomes. Bioanalysis 1, 1445-1459.
Guntuku, L., Gangasani, J. K., Thummuri, D., Borkar, R. M., Manavathi, B., Ragampeta, S., Vaidya, J. R., Sistla, R. and Vegi, N. G. M. 2019. Iitz-01, a novel potent lysosomotropic autophagy inhibitor, has single-agent antitumor efficacy in triple-negative breast cancer in vitro and in vivo. Oncogene 38, 581-595.
Huang, C. C., Chen, K. L., Cheung, C. H. A. and Chang, J. Y. 2013. Autophagy induced by cathepsin s inhibition induces early ros production, oxidative DNA damage, and cell death via xanthine oxidase. Free Radic. Biol. Med. 65, 1473-1486.
Jensen, A. B., Wynne, C., Ramirez, G., He, W., Song, Y., Berd, Y., Wang, H., Mehta, A. and Lombardi, A. 2010. The cathepsin k inhibitor odanacatib suppresses bone resorption in women with breast cancer and established bone metastases: Results of a 4-week, double-blind, randomized, controlled trial. Clin. Breast Cancer 10, 452-458.
Kagedal, K., Johansson, A. C., Johansson, U., Heimlich, G., Roberg, K., Wang, N. S., Jurgensmeier, J. M. and Ollinger, K. 2005. Lysosomal membrane permeabilization during apoptosis--involvement of bax? Int. J. Exp. Pathol. 86, 309-321.
Kagedal, K., Zhao, M., Svensson, I. and Brunk, U. T. 2001. Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem. J. 359, 335-343.
Kaur, J. and Debnath, J. 2015. Autophagy at the crossroads of catabolism and anabolism. Nat. Rev. Mol. Cell Biol. 16, 461-472.
Kaushik, S. and Cuervo, A. M. 2018. The coming of age of chaperone-mediated autophagy. Nat. Rev. Mol. Cell Biol. 19, 365-381.
Li, M. 2018. Enzyme replacement therapy: A review and its role in treating lysosomal storage diseases. Pediatr. Ann. 47, e191-e197.
Li, P., Gu, M. and Xu, H. 2019. Lysosomal ion channels as decoders of cellular signals. Trends Biochem. Sci. 44, 110-124.
Li, W. W., Li, J. and Bao, J. K. 2012. Microautophagy: Lesser-known self-eating. Cell. Mol. Life Sci. 69, 1125-1136.
Liu, S., Li, Y., Choi, H. M. C., Sarkar, C., Koh, E. Y., Wu, J. and Lipinski, M. M. 2018. Lysosomal damage after spinal cord injury causes accumulation of ripk1 and ripk3 proteins and potentiation of necroptosis. Cell Death Dis. 9, 476.
Logan, R., Funk, R. S., Axcell, E. and Krise, J. P. 2012. Drug-drug interactions involving lysosomes: Mechanisms and potential clinical implications. Expert Opin. Drug Metab. Toxicol. 8, 943-958.
Luzio, J. P., Parkinson, M. D., Gray, S. R. and Bright, N. A. 2009. The delivery of endocytosed cargo to lysosomes. Biochem. Soc. Trans. 37, 1019-1021.
Luzio, J. P., Pryor, P. R. and Bright, N. A. 2007. Lysosomes: Fusion and function. Nat. Rev. Mol. Cell Biol. 8, 622-632.
Luzio, J. P., Pryor, P. R., Gray, S. R., Gratian, M. J., Piper, R. C. and Bright, N. A. 2005. Membrane traffic to and from lysosomes. Biochem. Soc. Symp. 72, 77-86.
Manna, S. K., Zhang, H. J., Yan, T., Oberley, L. W. and Aggarwal, B. B. 1998. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappab and activated protein-1. J. Biol. Chem. 273, 13245-13254.
Mindell, J. A. 2012. Lysosomal acidification mechanisms. Annu. Rev. Physiol. 74, 69-86.
Molinari, A., Calcabrini, A., Meschini, S., Stringaro, A., Crateri, P., Toccacieli, L., Marra, M., Colone, M., Cianfriglia, M. and Arancia, G. 2002. Subcellular detection and localization of the drug transporter p-glycoprotein in cultured tumor cells. Curr. Protein Pept. Sci. 3, 653-670.
Morgan, A. J., Platt, F. M., Lloyd-Evans, E. and Galione, A. 2011. Molecular mechanisms of endolysosomal ca2+ signalling in health and disease. Biochem. J. 439, 349-374.
Nylandsted, J., Gyrd-Hansen, M., Danielewicz, A., Fehrenbacher, N., Lademann, U., Hoyer-Hansen, M., Weber, E., Multhoff, G., Rohde, M. and Jaattela, M. 2004. Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J. Exp. Med. 200, 425-435.
Park, E. J., Min, K. J., Choi, K. S., Kubatka, P., Kruzliak, P., Kim, D. E. and Kwon, T. K. 2016. Chloroquine enhances trail-mediated apoptosis through up-regulation of dr5 by stabilization of mrna and protein in cancer cells. Sci. Rep. 6, 22921.
Perera, R. M. and Zoncu, R. 2016. The lysosome as a regulatory hub. Annu. Rev. Cell Dev. Biol. 32, 223-253.
Platt, F. M. 2018. Emptying the stores: Lysosomal diseases and therapeutic strategies. Nat. Rev. Drug Discov. 17, 133-150.
Sancak, Y., Bar-Peled, L., Zoncu, R., Markhard, A. L., Nada, S. and Sabatini, D. M. 2010. Ragulator-rag complex targets mtorc1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 141, 290-303.
Saxton, R. A. and Sabatini, D. M. 2017. Mtor signaling in growth, metabolism, and disease. Cell 169, 361-371.
Seo, B. R., Min, K. J., Woo, S. M., Choe, M., Choi, K. S., Lee, Y. K., Yoon, G. and Kwon, T. K. 2017. Inhibition of cathepsin s induces mitochondrial ros that sensitizes trail-mediated apoptosis through p53-mediated downregulation of bcl-2 and c-flip. Antioxid. Redox Signal. 27, 215-233.
Seo, S. U., Min, K. J., Woo, S. M. and Kwon, T. K. 2018. Z-fl-cocho, a cathepsin s inhibitor, enhances oxaliplatin-mediated apoptosis through the induction of endoplasmic reticulum stress. Exp. Mol. Med. 50, 1-11.
Seo, S. U., Woo, S. M., Kim, M. W., Lee, H. S., Kim, S. H., Kang, S. C., Lee, E. W., Min, K. J. and Kwon, T. K. 2020. Cathepsin k inhibition-induced mitochondrial ros enhances sensitivity of cancer cells to anti-cancer drugs through usp27x-mediated bim protein stabilization. Redox Biol. 30, 101422.
Serrano-Puebla, A. and Boya, P. 2016. Lysosomal membrane permeabilization in cell death: New evidence and implications for health and disease. Ann. N. Y. Acad. Sci. 1371, 30-44.
Shachar, T., Lo Bianco, C., Recchia, A., Wiessner, C., RaasRothschild, A. and Futerman, A. H. 2011. Lysosomal storage disorders and parkinson's disease: Gaucher disease and beyond. Mov. Disord. 26, 1593-1604.
Shahriyar, S. A., Seo, S. U., Min, K. J., Kubatka, P., Min, D. S., Chang, J. S., Kim, D. E., Woo, S. M. and Kwon, T. K. 2020. Upregulation of dr5 and downregulation of survivin by iitz-01, lysosomotropic autophagy inhibitor, potentiates trail-mediated apoptosis in renal cancer cells via ubiquitin-proteasome pathway. Cancers (Basel) 12, 2363.
Sudhan, D. R., Rabaglino, M. B., Wood, C. E. and Siemann, D. W. 2016. Cathepsin l in tumor angiogenesis and its therapeutic intervention by the small molecule inhibitor kgp94. Clin. Exp. Metastasis 33, 461-473.
Sukhai, M. A., Prabha, S., Hurren, R., Rutledge, A. C., Lee, A. Y., Sriskanthadevan, S., Sun, H., Wang, X., Skrtic, M., Seneviratne, A., Cusimano, M., Jhas, B., Gronda, M., MacLean, N., Cho, E. E., Spagnuolo, P. A., Sharmeen, S., Gebbia, M., Urbanus, M., Eppert, K., Dissanayake, D., Jonet, A., Dassonville-Klimpt, A., Li, X., Datti, A., Ohashi, P. S., Wrana, J., Rogers, I., Sonnet, P., Ellis, W. Y., Corey, S. J., Eaves, C., Minden, M. D., Wang, J. C., Dick, J. E., Nislow, C., Giaever, G. and Schimmer, A. D. 2013. Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors. J. Clin. Invest. 123, 315-328.
Thelen, A. M. and Zoncu, R. 2017. Emerging roles for the lysosome in lipid metabolism. Trends Cell Biol. 27, 833-850.
Torii, S., Shintoku, R., Kubota, C., Yaegashi, M., Torii, R., Sasaki, M., Suzuki, T., Mori, M., Yoshimoto, Y., Takeuchi, T. and Yamada, K. 2016. An essential role for functional lysosomes in ferroptosis of cancer cells. Biochem. J. 473, 769-777.
Trivedi, P. C., Bartlett, J. J. and Pulinilkunnil, T. 2020. Lysosomal biology and function: Modern view of cellular debris bin. Cells 9, 1131-1165.
Wang, F., Gomez-Sintes, R. and Boya, P. 2018. Lysosomal membrane permeabilization and cell death. Traffic 19, 918-931.
Wang, F., Zhang, Z., Leung, W. T., Chen, J., Yi, J., Ying, C., Yuan, M., Wang, M., Zhang, N., Qiu, X., Wang, L. and Wei, H. 2019. Hydroxychloroquine reverses the drug resistance of leukemic k562/adm cells by inhibiting autophagy. Mol. Med. Rep. 20, 3883-3892.
Wang, J. H., Redmond, H. P., Watson, R. W. and Bouchier-Hayes, D. 1997. Induction of human endothelial cell apoptosis requires both heat shock and oxidative stress responses. Am. J. Physiol. 272, C1543-1551.
Yamagishi, T., Sahni, S., Sharp, D. M., Arvind, A., Jansson, P. J. and Richardson, D. R. 2013. P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration. J. Biol. Chem. 288, 31761-31771.
Yang, Y., Lim, S. K., Choong, L. Y., Lee, H., Chen, Y., Chong, P. K., Ashktorab, H., Wang, T. T., Salto-Tellez, M., Yeoh, K. G. and Lim, Y. P. 2010. Cathepsin s mediates gastric cancer cell migration and invasion via a putative network of metastasis-associated proteins. J. Proteome Res. 9, 4767-4778.
Yu, L., McPhee, C. K., Zheng, L., Mardones, G. A., Rong, Y., Peng, J., Mi, N., Zhao, Y., Liu, Z., Wan, F., Hailey, D. W., Oorschot, V., Klumperman, J., Baehrecke, E. H. and Lenardo, M. J. 2010. Termination of autophagy and reformation of lysosomes regulated by mtor. Nature 465, 942-946.
Zhang, L., Wang, H., Xu, J., Zhu, J. and Ding, K. 2014. Inhibition of cathepsin s induces autophagy and apoptosis in human glioblastoma cell lines through ros-mediated pi3k/akt/mtor/p70s6k and jnk signaling pathways. Toxicol. Lett. 228, 248-259.
Zhang, Y., Liao, Z., Zhang, L. J. and Xiao, H. T. 2015. The utility of chloroquine in cancer therapy. Curr. Med. Res. Opin. 31, 1009-1013.
Zheng, X., Chu, F., Chou, P. M., Gallati, C., Dier, U., Mirkin, B. L., Mousa, S. A. and Rebbaa, A. 2009. Cathepsin l inhibition suppresses drug resistance in vitro and in vivo: A putative mechanism. Am. J. Physiol. Cell Physiol. 296, C65-74.
Zhitomirsky, B. and Assaraf, Y. G. 2016. Lysosomes as mediators of drug resistance in cancer. Drug Resist. Updat. 24, 23-33.
Zhu, X., Sun, Y., Chen, D., Li, J., Dong, X., Wang, J., Chen, H., Wang, Y., Zhang, F., Dai, J., Pirraco, R. P., Guo, S., Marques, A. P., Reis, R. L. and Li, W. 2017. Mastocarcinoma therapy synergistically promoted by lysosome dependent apoptosis specifically evoked by 5-fu@nanogel system with passive targeting and ph activatable dual function. J. Control. Release 254, 107-118.
Zou, J., Kawai, T., Tsuchida, T., Kozaki, T., Tanaka, H., Shin, K. S., Kumar, H. and Akira, S. 2013. Poly ic triggers a cathepsin d- and ips-1-dependent pathway to enhance cytokine production and mediate dendritic cell necroptosis. Immunity 38, 717-728.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.